Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEURANESTH: General vs Locoregional Anesthesia for CSDH
NCT03666949Unknown
- Sponsor
- CHU Caen Normandie
- Start
- May 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of lidocaine in chronic subdural hematoma (CSDH) (2 arms), sponsored by CHU Caen Normandie. Primary endpoint: Postoperative theoretical length of stay at 10 days. Status: unknown.
02
Drugs
lidocaine
03
Conditions
chronic subdural hematoma (CSDH)
Beyond the preview
Go deeper on NCT03666949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03666949.